| Size | Price | Stock | Qty |
|---|---|---|---|
| 50mg |
|
||
| 100mg |
|
||
| Other Sizes |
| Targets |
4-Nitrophenyl β-D-Cellobioside targets cellulase enzymes, specifically endoglucanases and β-glucosidases. The compound serves as a chromogenic substrate for these enzymes, releasing p-nitrophenol upon enzymatic cleavage, which can be detected spectrophotometrically.
|
|---|---|
| ln Vitro |
The in vitro activity of this compound is its function as a chromogenic substrate for cellulase enzymes. Upon enzymatic cleavage by cellulases, the substrate releases p-nitrophenol, which can be quantified by colorimetric detection at 405 nm. The compound has been used to characterize the function of endoglucanase 1 from T. harzianum and β-glucosidase from T. xylanolyticum.
|
| ln Vivo |
4-Nitrophenyl β-D-Cellobioside is not used as a therapeutic agent. Its in vivo utility is limited to research applications involving the measurement of cellulase activity. The compound is not intended for systemic therapeutic use.
|
| Enzyme Assay |
In vitro enzyme assays for this compound involve incubating the chromogenic substrate with cellulase enzyme preparations in appropriate buffer conditions. The enzyme cleaves the substrate, releasing p-nitrophenol, which is measured spectrophotometrically at 405 nm. The rate of p-nitrophenol release is proportional to cellulase activity.
|
| Cell Assay |
For in vitro cellular experiments, this compound is typically used in cell-free systems for enzyme activity assays. The substrate can be added to cell lysates or purified enzyme preparations to assess cellulase activity.
|
| Animal Protocol |
In vivo animal experiments with this compound are not typically performed, as the compound is used as an in vitro enzyme substrate. The compound is intended for research use only.
|
| ADME/Pharmacokinetics |
Pharmacokinetic properties of this compound have not been characterized, as it is a research-use enzyme substrate rather than a drug candidate. The compound has a molecular weight of 463.39 g/mol and should be stored at -20°C, protected from light.
|
| Toxicity/Toxicokinetics |
Toxicological data for this compound has not been systematically evaluated, as it is intended for research applications only and not for therapeutic use. Standard laboratory safety precautions should be observed when handling this chemical reagent.
|
| References |
|
| Additional Infomation |
4-Nitrophenyl beta-cellobioside is the (β)-isomer; see also (α)-anomer: 17400-77-0
4-Nitrophenyl β-D-Cellobioside is a chromogenic substrate for cellulase enzymes used to characterize endoglucanase and β-glucosidase activity. The compound has no clinical or therapeutic applications. |
| Molecular Formula |
C18H25NO13
|
|---|---|
| Molecular Weight |
463.39
|
| Exact Mass |
463.133
|
| CAS # |
3482-57-3
|
| PubChem CID |
165125
|
| Appearance |
Off-white to light yellow solid powder
|
| Density |
1.7 g/cm3
|
| Boiling Point |
795.6ºC at 760 mmHg
|
| Melting Point |
249-250ºC
|
| Flash Point |
435ºC
|
| Index of Refraction |
1.67
|
| LogP |
-2.6
|
| Hydrogen Bond Donor Count |
7
|
| Hydrogen Bond Acceptor Count |
13
|
| Rotatable Bond Count |
6
|
| Heavy Atom Count |
32
|
| Complexity |
612
|
| Defined Atom Stereocenter Count |
10
|
| SMILES |
C1=CC(=CC=C1[N+](=O)[O-])O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O[C@H]3[C@@H]([C@H]([C@@H]([C@H](O3)CO)O)O)O)O)O
|
| InChi Key |
IAYJZWFYUSNIPN-KFRZSCGFSA-N
|
| InChi Code |
InChI=1S/C18H25NO13/c20-5-9-11(22)12(23)14(25)18(30-9)32-16-10(6-21)31-17(15(26)13(16)24)29-8-3-1-7(2-4-8)19(27)28/h1-4,9-18,20-26H,5-6H2/t9-,10-,11-,12+,13-,14-,15-,16-,17-,18+/m1/s1
|
| Chemical Name |
(2S,3R,4S,5S,6R)-2-[(2R,3S,4R,5R,6S)-4,5-dihydroxy-2-(hydroxymethyl)-6-(4-nitrophenoxy)oxan-3-yl]oxy-6-(hydroxymethyl)oxane-3,4,5-triol
|
| HS Tariff Code |
2934.99.9001
|
| Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: Please store this product in a sealed and protected environment (e.g. under nitrogen), avoid exposure to moisture and light. |
| Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
| Solubility (In Vitro) |
H2O: 5 mg/mL (10.79 mM)
|
|---|---|
| Solubility (In Vivo) |
Note: Listed below are some common formulations that may be used to formulate products with low water solubility (e.g. < 1 mg/mL), you may test these formulations using a minute amount of products to avoid loss of samples.
Injection Formulations
Injection Formulation 1: DMSO : Tween 80： Saline = 10 : 5 : 85 (i.e. 100 μL DMSO stock solution → 50 μL Tween 80 → 850 μL Saline)(e.g. IP/IV/IM/SC) *Preparation of saline: Dissolve 0.9 g of sodium chloride in 100 mL ddH ₂ O to obtain a clear solution. Injection Formulation 2: DMSO : PEG300 ：Tween 80 : Saline = 10 : 40 : 5 : 45 (i.e. 100 μL DMSO → 400 μLPEG300 → 50 μL Tween 80 → 450 μL Saline) Injection Formulation 3: DMSO : Corn oil = 10 : 90 (i.e. 100 μL DMSO → 900 μL Corn oil) Example: Take the Injection Formulation 3 (DMSO : Corn oil = 10 : 90) as an example, if 1 mL of 2.5 mg/mL working solution is to be prepared, you can take 100 μL 25 mg/mL DMSO stock solution and add to 900 μL corn oil, mix well to obtain a clear or suspension solution (2.5 mg/mL, ready for use in animals). View More
Injection Formulation 4: DMSO : 20% SBE-β-CD in saline = 10 : 90 [i.e. 100 μL DMSO → 900 μL (20% SBE-β-CD in saline)] Oral Formulations
Oral Formulation 1: Suspend in 0.5% CMC Na (carboxymethylcellulose sodium) Oral Formulation 2: Suspend in 0.5% Carboxymethyl cellulose Example: Take the Oral Formulation 1 (Suspend in 0.5% CMC Na) as an example, if 100 mL of 2.5 mg/mL working solution is to be prepared, you can first prepare 0.5% CMC Na solution by measuring 0.5 g CMC Na and dissolve it in 100 mL ddH2O to obtain a clear solution; then add 250 mg of the product to 100 mL 0.5% CMC Na solution, to make the suspension solution (2.5 mg/mL, ready for use in animals). View More
Oral Formulation 3: Dissolved in PEG400 (Please use freshly prepared in vivo formulations for optimal results.) |
| Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
| 1 mM | 2.1580 mL | 10.7900 mL | 21.5801 mL | |
| 5 mM | 0.4316 mL | 2.1580 mL | 4.3160 mL | |
| 10 mM | 0.2158 mL | 1.0790 mL | 2.1580 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration： mg/mL；
Method for preparing DMSO stock solution： mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation:：Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O，mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.
Products are for research use only; We do not sell to patients
Copyright 2020 InvivoChem LLC | All Rights Reserved
